G2X TAKE: Infotrend, a fast growing 8(a) small business boutique Information Technology, eDiscovery and litigation support leader, was recently awarded a 3-year contract to support ongoing ESP efforts with the Food and Drug Administration. This contract was awarded as an 8(a) sole source action.
- This win builds on Infotrend’s prior experience providing support to the FDA Center for Drug Evaluation and Research (CDER) Electronic Submissions Program and adds to their broad set of past performance that cuts across numerous Federal Civilian and Financial agencies (More here).
- Led by CEO, Gurpreet Singh, Infotrend has seen significant growth of late, to include being noted as one of the Rising Federal Civilian-focused Companies Recognized by Inc. for Astounding Growth, and being named to the list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come. More here.
Award ID: 75F40121C00030